Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mirror Biologics, Inc. logo — A clinical-stage immunotherapy company with “off-the-shelf”,...

Mirror Biologics, Inc.

A clinical-stage immunotherapy company with “off-the-shelf”, disease agnostic, cell therapy for metastatic cold tumors

Founded 2019 United States Wesley Chapel, United States 22 employees Biotechnology, Health Care +1

General Information

Company Name Mirror Biologics, Inc.
Founded Year 2019
Location United States Wesley Chapel, United States +2
Employees 22
Industries Biotechnology, Health Care, Manufacturing
Social

Get notified when Mirror Biologics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mirror Biologics, Inc.

Mirror Biologics, Inc. is a clinical-stage immunotherapy company headquartered in Tampa, Florida, with operations spanning Jerusalem, Israel, Kuala Lumpur, Malaysia, and Bangkok, Thailand. The company's primary focus is the development of "off-the-shelf" living immune cell therapies for metastatic solid tumors and a universal vaccine against respiratory viral infections in the elderly. With a 21 CFR 1271 registered blood donor center and advanced bioreactor research in Tampa, a GMP cell manufacturing facility in Jerusalem, and clinical support and distribution operations in Bangkok and Kuala Lumpur, Mirror Biologics is strategically positioned for global impact. The company's innovative Mirror Effect technology platform, protected by over 200 patents, allows for the reverse engineering and imprinting of effective immune responses, while AlloStim®—Mirror Biologics' lead drug—differentiates itself as a patented, disease-agnostic, allogeneic living immune cell. The unique feature of AlloStim® lies in its ability to imprint a protective or therapeutic cellular immune response customized to a patient's resident disease without requiring prior knowledge of the disease or genetic properties. Furthermore, the development of proprietary "artificial lymph node" bioreactors and novel frozen dosage forms underscores the company's commitment to scalable and cost-effective solutions. Notably, Mirror Biologics acquired the exclusive, worldwide rights to AlloStim® and the Mirror Effect technology platform from Immunovative Therapies, Ltd, an Israeli company. Founded in 2019, Mirror Biologics operates within the Biotechnology, Health Care, and Manufacturing industries, showcasing a unique and promising approach to immunotherapy. With a strong foundation and a clear vision for the future, the company's efforts are poised to make significant strides in the field of immunotherapy and beyond.

Taxonomy: immunotherapy, cell therapy, biopharmaceutical, clinical-stage, metastatic tumors, living immune cell therapies, vaccine development, bioreactor research, cell therapy manufacturing, clinical immunology, GMP cell manufacturing, patented technology, disease-agnostic treatments, bioreactor development, exclusive rights acquisition

No funding data available for Mirror Biologics, Inc. yet.

Get notified when Mirror Biologics, Inc. raises funding

FAQ About Mirror Biologics, Inc.

A clinical-stage immunotherapy company with “off-the-shelf”, disease agnostic, cell therapy for metastatic cold tumors
Mirror Biologics, Inc. was founded in 2019.
Mirror Biologics, Inc. is headquartered in Wesley Chapel, United States.
Mirror Biologics, Inc. operates in the following industries: Biotechnology, Health Care, Manufacturing.
Mirror Biologics, Inc. has approximately 22 employees.

We're actively collecting intelligence on Mirror Biologics, Inc..

Track Mirror Biologics, Inc. to get notified

Don't just browse. Track.

Signal Tracker monitors Mirror Biologics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes